InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (12 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
12
T+90 hit rate
44%
T+90 mean return
+18.2%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Peetz Christopher, Chairman & CEO. Officer active across 3 companies, notably Mirum Pharmaceuticals, Inc.. In total, 34 disclosures have been logged. Split: 4 buys · 12 sells. Total volume traded: €3.6m. Activity tracked since 10 May 2021. The latest transaction was filed on 6 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations34 total
20,000 shares@ US$2.936Common StockSEC:0001614740-26-000011:0
12,134 shares@ US$121.65Common StockSEC:0001614740-26-000011:1
4,181 shares@ US$122.34Common StockSEC:0001614740-26-000011:2
1,975 shares@ US$123.74Common StockSEC:0001614740-26-000011:3
1,710 shares@ US$124.79Common StockSEC:0001614740-26-000011:4
50,000 sharesCommon StockSEC:0001415889-25-008556:0
40,000 shares@ US$2.9366.6% of flowCommon StockSEC:0001415889-25-006524:0
9,102 shares@ US$48.222524.9% of flowCommon StockSEC:0001415889-25-002981:0
12,500 sharesCommon StockSEC:0001415889-25-002134:0
7,489 shares@ US$42.815317.9% of flowCommon StockSEC:0001415889-25-001143:0
65 shares@ US$21.0460.1% of flowCommon StockSEC:0001415889-24-026868:0
34,013 shares@ US$2.9365.4% of flowCommon StockSEC:0001415889-24-020053:0
1,900 sharesCommon StockSEC:0001626199-24-000101:0
817 shares@ US$21.0460.9% of flowCommon StockSEC:0001415889-24-013355:0
5,159 shares@ US$20.62235.8% of flowCommon StockSEC:0001415889-24-008313:0
6,013 shares@ US$26.19188.4% of flowCommon StockSEC:0001415889-24-002754:0
5,209 shares@ US$28.03487.8% of flowCommon StockSEC:0001415889-24-000881:0
5,498 shares@ US$25.64667.5% of flowCommon StockSEC:0001209191-23-041330:0
1,256 shares@ US$16.92351.1% of flowCommon StockSEC:0001209191-23-030951:0
50,000 shares0Common StockSEC:0001209191-23-006297:0
49 shares@ US$17.0510.0% of flowCommon StockSEC:0001209191-22-056890:0
1,500 shares@ US$13.5660.0005% mcap8.3% of flowCommon STockSEC:0001209191-22-028722:0
40,000 shares0Common StockSEC:0001209191-22-002429:0
40,000 shares0Common StockSEC:0001209191-22-002429
7,000 shares@ US$14.405.2% of flowCommon StockSEC:0001209191-21-067067
Ideal exit: 21 Aug 2022 (T+270)
25 of 34 declarations
About Peetz Christopher
Christopher Peetz is the President and CEO of Mirum Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc. He oversees the operations and strategy of both companies, focusing on innovation in the pharmaceutical sector. His leadership is essential for their success.
